| 40488-9 |
Glucose/Creatinine |
Ratio |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Glucose/Creatinine [Ratio] in Urine |
|
MIN |
DefinitionDescription |
|
|
mmol/g creatinine |
|
|
|
|
|
|
CHEM |
|
40488-9 |
|
|
|
|
Both |
|
|
|
0 |
Glucose/Creat Ur-Rto |
|
|
|
N |
|
Chemistry; CR; Crea; Creat; Glu; Gluc; Glucoseur; Point in time; QNT; Quan; Quant; Quantitative; Random; Ratios; Rto; UA; UCr; UR; Urn |
2.7 |
2.15 |
|
|
|
|
|
|
|
mmol/g{creat} |
|
|
|
0 |
| 40489-7 |
Histiocytes/Cells |
NFr |
Synv fld |
Pt |
Qn |
Manual count |
|
ACTIVE |
Histiocytes/cells in Synovial fluid by Manual count |
|
NAM |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
HEM/BC |
|
40489-7 |
|
Manual count |
|
|
Observation |
|
|
|
0 |
Histiocytes NFr Snv Manual |
|
|
|
N |
|
Cell; Cellularity; HEMATOLOGY/CELL COUNTS; Histiocyte; Histocytes; Joint aspirate; Joint fld; Joint flu; Joint fluid; Manl; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; SF; SNV; Syn; Syn fl; Synov; Synovial fluid |
2.79 |
2.15 |
|
|
|
|
|
|
|
% |
|
|
Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; |
0 |
| 4049-3 |
Theophylline |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Theophylline [Mass/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
4049-3 |
|
|
|
|
Both |
|
|
|
0 |
Theophylline SerPl-mCnc |
|
|
|
Y |
|
Aminophylline; Biophyllin; Continus; DRUG/TOXICOLOGY; Drugs; Lasma; Level; Mass concentration; Nuelin; Phyllocontin; Pl; Plasma; Plsm; Point in time; Pro-vent; QNT; Quan; Quant; Quantitative; Random; Sabidal SR; SerP; SerPl; SerPlas; Serum; Serum or plasma; Slo-Phyllin; Somophyllin; Somophylline; SR; Theo; Theo-dur; Theolair; Uniphyllin; UniversalLabOrders |
2.73 |
1 |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
| 40490-5 |
Macrophages/Leukocytes |
NFr |
Synv fld |
Pt |
Qn |
Manual count |
|
ACTIVE |
Macrophages/Leukocytes in Synovial fluid by Manual count |
|
NAM |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
HEM/BC |
|
40490-5 |
|
Manual count |
|
|
Observation |
|
|
|
0 |
Macrophages NFr Snv Manual |
|
|
|
N |
|
HEMATOLOGY/CELL COUNTS; Joint aspirate; Joint fld; Joint flu; Joint fluid; Leuc; Leuk; Leukocyte; Lkcs; Macrop; Macrophage; Macros; Macrphg; Manl; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; SF; SNV; Syn; Syn fl; Synov; Synovial fluid; WBC; WBCs; White blood cell; White blood cells |
2.79 |
2.15 |
|
|
|
|
|
|
|
% |
|
|
Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; |
0 |
| 40491-3 |
Neutrophils/Leukocytes |
NFr |
Synv fld |
Pt |
Qn |
Manual count |
|
ACTIVE |
Neutrophils/Leukocytes in Synovial fluid by Manual count |
|
NAM |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
HEM/BC |
|
40491-3 |
|
Manual count |
|
|
Observation |
|
|
|
0 |
Neutrophils NFr Snv Manual |
|
|
|
N |
|
HEMATOLOGY/CELL COUNTS; Joint aspirate; Joint fld; Joint flu; Joint fluid; Leuc; Leuk; Leukocyte; Lkcs; Manl; Neut; Neutr; Neutrophil; Number fraction; Percent; PMN; PNM; Point in time; QNT; Quan; Quant; Quantitative; Random; Rheum; Rheumatology; SF; SNV; Syn; Syn fl; Synov; Synovial fluid; WBC; WBCs; White blood cell; White blood cells |
2.79 |
2.15 |
|
|
|
|
|
|
|
% |
|
|
Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; |
0 |
| 40492-1 |
Plasma cells/Leukocytes |
NFr |
Synv fld |
Pt |
Qn |
Manual count |
|
ACTIVE |
Plasma cells/Leukocytes in Synovial fluid by Manual count |
|
NAM |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
HEM/BC |
|
40492-1 |
|
Manual count |
|
|
Observation |
|
|
|
0 |
Plasma Cells NFr Snv Manual |
|
|
|
N |
|
Cell; Cellularity; HEMATOLOGY/CELL COUNTS; Joint aspirate; Joint fld; Joint flu; Joint fluid; Leuc; Leuk; Leukocyte; Lkcs; Manl; Myeloma cells; Number fraction; Percent; Plasmacyte; Plasmacytes; Point in time; QNT; Quan; Quant; Quantitative; Random; SF; SNV; Syn; Syn fl; Synov; Synovial fluid; WBC; WBCs; White blood cell; White blood cells |
2.79 |
2.15 |
|
|
|
|
|
|
|
% |
|
|
Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; |
0 |
| 40493-9 |
Methylenedioxymethamphetamine |
PrThr |
Ser/Plas |
Pt |
Ord |
|
|
ACTIVE |
Methylenedioxymethamphetamine [Presence] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
40493-9 |
|
|
|
|
Both |
|
|
|
0 |
MDMA SerPl Ql |
|
|
|
N |
|
Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Ecstasy; Illicit; MDMA; Ordinal; Pl; Plasma; Plsm; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
2.15 |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 40494-7 |
Yersinia pseudotuberculosis Ab |
Titr |
Ser |
Pt |
SemiQn |
Aggl |
|
ACTIVE |
Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
40494-7 |
|
Aggl |
|
|
Both |
|
|
|
0 |
Y pseudoTB Ab Titr Ser Aggl |
|
|
|
N |
|
ABS; Aby; Agg; Agglut; Agglutination; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr; Y pseudoTB; Y pseudotuberculosis |
2.75 |
2.15 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 40495-4 |
Yersinia pseudotuberculosis 3 Ab |
Titr |
Ser |
Pt |
SemiQn |
|
|
ACTIVE |
Yersinia pseudotuberculosis 3 Ab [Titer] in Serum |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
40495-4 |
|
|
|
|
Both |
|
|
|
0 |
Y pseudoTB 3 Ab Titr Ser |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); ID; III; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr; Y pseudoTB; Y pseudoTB 3; Y pseudotuberculosis |
2.75 |
2.15 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 40496-2 |
Yersinia pseudotuberculosis 2 Ab |
Titr |
Ser |
Pt |
SemiQn |
|
|
ACTIVE |
Yersinia pseudotuberculosis 2 Ab [Titer] in Serum |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
40496-2 |
|
|
|
|
Both |
|
|
|
0 |
Y pseudoTB 2 Ab Titr Ser |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); ID; II; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr; Y pseudoTB; Y pseudoTB 2; Y pseudotuberculosis |
2.75 |
2.15 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 40497-0 |
Yersinia pseudotuberculosis 1 Ab |
Titr |
Ser |
Pt |
SemiQn |
|
|
ACTIVE |
Yersinia pseudotuberculosis 1 Ab [Titer] in Serum |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
40497-0 |
|
|
|
|
Both |
|
|
|
0 |
Y pseudoTB 1 Ab Titr Ser |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); i; ID; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr; Y pseudoTB; Y pseudoTB 1; Y pseudotuberculosis |
2.75 |
2.15 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 40498-8 |
Yersinia enterocolitica Ab |
Titr |
Ser |
Pt |
SemiQn |
Aggl |
|
ACTIVE |
Yersinia enterocolitica Ab [Titer] in Serum by Agglutination |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
40498-8 |
|
Aggl |
|
|
Both |
|
|
|
0 |
Y enterocol Ab Titr Ser Aggl |
|
|
|
N |
|
ABS; Aby; Agg; Agglut; Agglutination; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr; Y enterocol; Y enterocolitica |
2.75 |
2.15 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 40499-6 |
Lymphocytic choriomeningitis virus Ab.IgM |
Titr |
Ser |
Pt |
SemiQn |
IA |
|
ACTIVE |
Lymphocytic choriomeningitis virus IgM Ab [Titer] in Serum by Immunoassay |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
40499-6 |
|
IA |
|
|
Both |
|
|
|
0 |
LCMV IgM Titr Ser IA |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; LCMV; MEIA; Microbiology; Point in time; Random; Serum; SmQn; SR; SUDS; Titer; Titered; Titre; Ttr |
2.75 |
2.15 |
|
|
|
|
|
|
|
{titer} |
|
|
The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 405-1 |
Pipemidate |
Susc |
Isolate |
Pt |
OrdQn |
Agar diffusion |
|
ACTIVE |
Pipemidate [Susceptibility] by Disk diffusion (KB) |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ABXBACT |
|
405-1 |
|
Agar diffusion |
|
|
Observation |
|
|
|
0 |
Pipemidate Islt KB |
|
|
|
|
|
Acipern; ANTIBIOTIC SUSCEPTIBILITIES; AST; Biopim; Cistomid; Deblaston; Diperpen; Disk diffusion; Dokol; Faremid; Filtrax; Galusan; ID; Impresial; Infectious Disease; InfectiousDisease; Islt; Isol; KB; Kirby-bauer; Nuril; Pipeacid; Pipedac; Pipedose; Pipefort; Pipemid; Pipemidic acid; Piperamic acid; Pipram; Pipurin; Point in time; Pro-uro; Random; Septidron; Solupemid; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Tractur; Urisan; Urodene |
2.21 |
1 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 4050-1 |
Thiopental |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Thiopental [Mass/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
4050-1 |
|
|
|
|
Both |
|
|
|
0 |
Thiopental SerPl-mCnc |
|
|
|
Y |
|
Barbiturate; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pentothal; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
1 |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
| 40500-1 |
Lymphocytic choriomeningitis virus Ab.IgG |
Titr |
Ser |
Pt |
SemiQn |
IA |
|
ACTIVE |
Lymphocytic choriomeningitis virus IgG Ab [Titer] in Serum by Immunoassay |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
40500-1 |
|
IA |
|
|
Both |
|
|
|
0 |
LCMV IgG Titr Ser IA |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; LCMV; MEIA; Microbiology; Point in time; Random; Serum; SmQn; SR; SUDS; Titer; Titered; Titre; Ttr |
2.75 |
2.15 |
|
|
|
|
|
|
|
{titer} |
|
|
The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 40501-9 |
Candida sp Ab |
Titr |
Ser |
Pt |
SemiQn |
LA |
|
ACTIVE |
Candida sp Ab [Titer] in Serum by Latex agglutination |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
40501-9 |
|
LA |
|
|
Both |
|
|
|
0 |
Candida Ab Titr Ser LA |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cand; Candidiasis; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; LAT; Latex agglutination; Microbiology; Monilia; Point in time; Random; Serum; SmQn; species; spp; SR; Thrush; Titer; Titered; Titre; Ttr |
2.75 |
2.15 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 40502-7 |
Saint Louis encephalitis virus Ab |
Titr |
Ser |
Pt |
SemiQn |
Comp fix |
|
ACTIVE |
Saint Louis encephalitis virus Ab [Titer] in Serum by Complement fixation |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
40502-7 |
|
Comp fix |
|
|
Both |
|
|
|
0 |
SLEV Ab Titr Ser CF |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CF; Comp fixation; Compfix; Complement fixation; Dilution factor; Dilution Factor (Titer); Enc; Enceph; Encephalomyelitis; ID; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; Serum; SLE virus; SLEV; SmQn; SR; St Louis; Titer; Titered; Titre; Ttr |
2.75 |
2.15 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 40503-5 |
Sindbis virus Ab |
Titr |
Ser |
Pt |
SemiQn |
HAI |
|
ACTIVE |
Sindbis virus Ab [Titer] in Serum by Hemagglutination inhibition |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
40503-5 |
|
HAI |
|
|
Both |
|
|
|
0 |
SINV Ab Titr Ser HAI |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); HEMAGGLUTINATION INHIBITION; HI; ID; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; Serum; SINV; SmQn; SR; Titer; Titered; Titre; Ttr |
2.75 |
2.15 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 40504-3 |
Powassan virus Ab |
Titr |
Ser |
Pt |
SemiQn |
Comp fix |
|
ACTIVE |
Powassan virus Ab [Titer] in Serum by Complement fixation |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
40504-3 |
|
Comp fix |
|
|
Both |
|
|
|
0 |
POWV Ab Titr Ser CF |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CF; Comp fixation; Compfix; Complement fixation; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; Microbiology; Point in time; POWV; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr |
2.75 |
2.15 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 40505-0 |
Chikungunya virus Ab |
Titr |
Ser |
Pt |
SemiQn |
HAI |
|
ACTIVE |
Chikungunya virus Ab [Titer] in Serum by Hemagglutination inhibition |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
40505-0 |
|
HAI |
|
|
Both |
|
|
|
0 |
CHIKV Ab Titr Ser HAI |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CHIKV; Dilution factor; Dilution Factor (Titer); HEMAGGLUTINATION INHIBITION; HI; ID; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr |
2.75 |
2.15 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 40506-8 |
Jamestown canyon virus Ab |
Titr |
Ser |
Pt |
SemiQn |
IF |
|
ACTIVE |
Jamestown canyon virus Ab [Titer] in Serum by Immunofluorescence |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
40506-8 |
|
IF |
|
|
Both |
|
|
|
0 |
JCV Ab Titr Ser IF |
|
|
|
N |
|
ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; JCV; Microbiology; Point in time; Random; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr |
2.75 |
2.15 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 40507-6 |
Jamestown canyon virus Ab |
Titr |
Ser |
Pt |
SemiQn |
HAI |
|
ACTIVE |
Jamestown canyon virus Ab [Titer] in Serum by Hemagglutination inhibition |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
40507-6 |
|
HAI |
|
|
Both |
|
|
|
0 |
JCV Ab Titr Ser HAI |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); HEMAGGLUTINATION INHIBITION; HI; ID; Infectious Disease; InfectiousDisease; JCV; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr |
2.75 |
2.15 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 40508-4 |
Jamestown canyon virus Ab.IgM |
Titr |
Ser |
Pt |
SemiQn |
Neut |
|
ACTIVE |
Jamestown canyon virus IgM Ab [Titer] in Serum by Neutralization test |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
40508-4 |
|
Neut |
|
|
Both |
|
|
|
0 |
JCV IgM Titr Ser Nt |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Conventional virus neutralization test; cVNT; Dilution factor; Dilution Factor (Titer); ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; JCV; Microbiology; NEUTRALIZATION; Neutralization test; NT; Point in time; Random; Serum; Serum virus neutralization; SmQn; SR; SVN; Titer; Titered; Titre; Ttr; Virus neutralization test; VNT |
2.75 |
2.15 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 40509-2 |
Snowshoe hare virus Ab.IgM |
Titr |
Ser |
Pt |
SemiQn |
Neut |
|
ACTIVE |
Snowshoe hare virus IgM Ab [Titer] in Serum by Neutralization test |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
40509-2 |
|
Neut |
|
|
Both |
|
|
|
0 |
SSHV IgM Titr Ser Nt |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Conventional virus neutralization test; cVNT; Dilution factor; Dilution Factor (Titer); ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; NEUTRALIZATION; Neutralization test; NT; Point in time; Random; Serum; Serum virus neutralization; SmQn; SR; SSHV; SVN; Titer; Titered; Titre; Ttr; Virus neutralization test; VNT |
2.75 |
2.15 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
